More than 140,000 bottles of a prescription cholesterol medication have been recalled due to “failed dissolution specifications,” the Food and Drug Administration announced earlier this month. Ascend Laboratories of New Jersey recalled certain bottles of Atorvastatin Calcium tablets, a generic version of Lipitor, sold nationwide. The recall was announced on Sept. 19 and given a Class II risk level on …
Read More »FDA Announces Nationwide Recall of Cholesterol Medication—More Than 140,000 Bottles Affected
:max_bytes(150000):strip_icc()/CopyofStockPhotoRedBadge1-2cf45a30b5834fa592715da77a3ec0dd.png "FDA Announces Nationwide Recall of Cholesterol Medication—More Than 140,000 Bottles Affected")